Article thumbnail

Increased Risk for Invasive Breast Cancer Associated with Hormonal Therapy: A Nation-Wide Random Sample of 65,723 Women Followed from 1997 to 2008

By Jung-Nien Lai, Chien-Tung Wu, Pau-Chung Chen, Chiun-Sheng Huang, Song-Nan Chow and Jung-Der Wang
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1999). Association between use of unconventional therapies and conventional medical services.
  2. (2003). Breast cancer and hormone-replacement therapy in the Million Women Study.
  3. (2006). Breast cancer risk in postmenopausal women using estrogen-only therapy.
  4. (1999). Breast-cancer risk following long-term oestrogen- and oestrogen-progestinreplacement therapy.
  5. (2007). Changes in practice since the publication in 2007 of further results from the Women’s Health Initiative and the Million Women Study.
  6. (2010). Comparative analysis of breast cancer risk factors among Hispanic and non-Hispanic white women.
  7. (2004). Determination of phytoestrogens in traditional medicinal herbs using gas chromatography–mass spectrometry.
  8. (1979). Disease Control and Prevention
  9. (2010). Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.
  10. (2009). Estrogenic activities of extracts of Chinese licorice (Glycyrrhiza uralensis) root in MCF-7 breast cancer cells.
  11. (2002). Estrogenic activity of herbs commonly used as remedies for menopausal symptoms.
  12. (2004). Government Information Office
  13. (2006). High-performance thin-layer chromatographic fingerprints of isoflavonoids for distinguishing between Radix Puerariae Lobate and Radix Puerariae Thomsonii.
  14. (2004). Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
  15. (2007). Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years’ National Cohort study.
  16. (2007). How the Women’s Health Initiative (WHI) influenced physicians’ practice and attitudes.
  17. (2004). Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
  18. (2003). Issues to debate on the Women’s Health Initiative (WHI) study. Epidemiology or randomized clinical trials–time out for hormone replacement therapy studies?
  19. (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
  20. (2009). Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.
  21. (2002). Phyto-oestrogens and cancer.
  22. (2003). Phytoestrogens in botanical dietary supplements: implications for cancer.
  23. (2010). Postmenopausal hormone therapy: an Endocrine Society scientific statement.
  24. (2005). Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
  25. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial.
  26. (2008). The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.
  27. (1995). The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
  28. (2006). Trends in breast cancer by race and ethnicity: update
  29. (2010). Women gynecologists’ attitude toward their own health.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.